Anal Squamous Intraepithelial Lesions and Anal Cancer Management in Low Resource Settings
- 13 September 2022
- journal article
- review article
- Published by Georg Thieme Verlag KG in Clinics in Colon and Rectal Surgery
- Vol. 35 (05) , 396-401
Abstract
A low resource setting (LRS) is defined as a health care system which does not meet the criteria defined by the World Health Organization (WHO) or other national/international organizations in the following areas: infrastructure, materials, and human resources.1 Patients encounter barriers which limit their access to care and services that are considered standard of care. While LRS is most commonly associated with developing countries, it is easy to overlook communities in developed countries which lack the financial resources to afford basic health care. This article describes the societal implications and barriers to care for both squamous intraepithelial lesions (SILs) and anal cancer in LRS, the existing screening/surveillance approaches, available treatment approaches to anal cancer, and it also discusses potential evidence-based approaches to bridge the gap for these disparities in anal cancer care. Article published online: 13 September 2022 © 2022. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAKeywords
This publication has 55 references indexed in Scilit:
- Public health and research funding for childhood neurodevelopmental disorders in Sub-Saharan Africa: a time to balance prioritiesHealthcare in Low-resource Settings, 2014
- Current treatment options for management of anal intraepithelial neoplasiaOncoTargets and Therapy, 2013
- Universal routine HPV vaccination for young girls in Uganda: a review of opportunities and potential obstaclesInfectious Agents and Cancer, 2012
- Achieving high coverage in Rwanda’s national human papillomavirus vaccination programmeBulletin of the World Health Organization, 2012
- A Cross-Sectional Study of HPV Vaccine Acceptability in Gaborone, BotswanaPLOS ONE, 2011
- A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimodAIDS, 2010
- Addressing Anal Health in the HIV Primary Care Setting: A Disappointing RealityAIDS Patient Care and STDs, 2010
- Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settingsVaccine, 2009
- HIV Prevalence, Risks for HIV Infection, and Human Rights among Men Who Have Sex with Men (MSM) in Malawi, Namibia, and BotswanaPLOS ONE, 2009
- High Resolution Anoscopy Findings for Men Who Have Sex with Men: Inaccuracy of Anal Cytology as a Predictor of Histologic High-Grade Anal Intraepithelial Neoplasia and the Impact of HIV SerostatusClinical Infectious Diseases, 2004